Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

LNTH

Lantheus Holdings, Inc.

CIK 0001521036 · Nasdaq

NasdaqHealth CareIn Vitro & In Vivo Diagnostic Substances
$105.99
↓ 0.76 (-0.71%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals, Ownership, Technicals, Options

Key stats

Market Cap
$6.90B
P/E Ratio
24.73
EPS
3.46
Dividend Yield
Not covered
52W Position
91%
Beta
0.42

Valuation multiples

Fwd P/E
19.19
PEG
0.61
P/B
5.69
P/S
4.46
EV/Revenue
4.14
ROE
23.0%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 91%
$47.25$111.86

Latest Financials

2025-12-31 FY
Revenue
$1.54B
Net Income
$233.56M
Total Assets
$2.23B
Free Cash Flow
$354.05M

Recent news